These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 34896194)

  • 1. Nonclinical toxicology development of a novel antibody antibiotic conjugate for treating invasive Staphylococcus Aureus infections.
    Stagg NJ; Katavolos P; Achilles Poon K; Zhong S; Ljumanovic N; Kamath A; Cai H; Carrasco-Triguero M; Halpern W
    Toxicol Appl Pharmacol; 2022 Jan; 435():115811. PubMed ID: 34896194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical and translational pharmacokinetics of a novel THIOMAB™ antibody-antibiotic conjugate against
    Deng R; Zhou C; Li D; Cai H; Sukumaran S; Carrasco-Triguero M; Saad O; Nazzal D; Lowe C; Ramanujan S; Kamath AV
    MAbs; 2019; 11(6):1162-1174. PubMed ID: 31219754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of DSTA4637A: A novel THIOMAB™ antibody antibiotic conjugate against Staphylococcus aureus in mice.
    Zhou C; Lehar S; Gutierrez J; Rosenberger CM; Ljumanovic N; Dinoso J; Koppada N; Hong K; Baruch A; Carrasco-Triguero M; Saad O; Mariathasan S; Kamath AV
    MAbs; 2016; 8(8):1612-1619. PubMed ID: 27653831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Tissue Distribution, Catabolism, and Elimination of an Anti-
    Cai H; Yip V; Lee MV; Wong S; Saad O; Ma S; Ljumanovic N; Khojasteh SC; Kamath AV; Shen BQ
    Drug Metab Dispos; 2020 Nov; 48(11):1161-1168. PubMed ID: 32839277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal physiologically-based pharmacokinetic modeling of DSTA4637A, A novel THIOMAB™ antibody antibiotic conjugate against Staphylococcus aureus, in a mouse model.
    Wang-Lin SX; Zhou C; Kamath AV; Hong K; Koppada N; Saad OM; Carrasco-Triguero M; Khojasteh C; Deng R
    MAbs; 2018 Oct; 10(7):1131-1143. PubMed ID: 30081725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Phase 1, Randomized, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S, an Anti-
    Peck M; Rothenberg ME; Deng R; Lewin-Koh N; She G; Kamath AV; Carrasco-Triguero M; Saad O; Castro A; Teufel L; Dickerson DS; Leonardelli M; Tavel JA
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910894
    [No Abstract]   [Full Text] [Related]  

  • 7. Sustained activity of novel THIOMAB antibody-antibiotic conjugate against Staphylococcus aureus in a mouse model: Longitudinal pharmacodynamic assessment by bioluminescence imaging.
    Zhou C; Cai H; Baruch A; Lewin-Koh N; Yang M; Guo F; Xu D; Deng R; Hazenbos W; Kamath AV
    PLoS One; 2019; 14(10):e0224096. PubMed ID: 31661493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonclinical Profile of PF-06952229 (MDV6058), a Novel TGFβRI/Activin Like Kinase 5 Inhibitor Supports Clinical Evaluation in Cancer.
    Guha M; Thibault S; Pham S; Bernales S; Pai R; Herrera FJ; Johnson TR; Vitsky A; Fernando T; Finkelstein M
    J Pharmacol Exp Ther; 2024 Oct; 391(2):335-345. PubMed ID: 39284628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential responses to JNJ-37822681, a specific and fast dissociating dopamine D2 receptor antagonist, in cynomolgus monkey and Sprague-Dawley rat general toxicology studies: clinical observations, prolactin levels, mammary histopathology findings and toxicokinetics.
    de Waal EJ; Desmidt M; Korte S; Niehoff M; Chase K; Arrowsmith W; Lampo A
    J Appl Toxicol; 2014 Sep; 34(9):974-92. PubMed ID: 24105799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Potent Pan-TGFβ Neutralizing Monoclonal Antibody Elicits Cardiovascular Toxicity in Mice and Cynomolgus Monkeys.
    Mitra MS; Lancaster K; Adedeji AO; Palanisamy GS; Dave RA; Zhong F; Holdren MS; Turley SJ; Liang WC; Wu Y; Meng YG; Vernes JM; Schutten MM
    Toxicol Sci; 2020 May; 175(1):24-34. PubMed ID: 32077954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicologic evaluations of an immunotoxin, H65-RTA.
    Kung AH; Cavagnaro JA; Makin A; White MA; Kong KN
    Fundam Appl Toxicol; 1995 Jun; 26(1):75-84. PubMed ID: 7657064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Male and female fertility assessment in the cynomolgus monkey following administration of ABT-874, a human Anti-IL-12/23p40 monoclonal antibody.
    Enright BP; Tornesi B; Weinbauer GF; Blaich G
    Birth Defects Res B Dev Reprod Toxicol; 2012 Dec; 95(6):421-30. PubMed ID: 23213064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel antibody-antibiotic conjugate eliminates intracellular S. aureus.
    Lehar SM; Pillow T; Xu M; Staben L; Kajihara KK; Vandlen R; DePalatis L; Raab H; Hazenbos WL; Morisaki JH; Kim J; Park S; Darwish M; Lee BC; Hernandez H; Loyet KM; Lupardus P; Fong R; Yan D; Chalouni C; Luis E; Khalfin Y; Plise E; Cheong J; Lyssikatos JP; Strandh M; Koefoed K; Andersen PS; Flygare JA; Wah Tan M; Brown EJ; Mariathasan S
    Nature; 2015 Nov; 527(7578):323-8. PubMed ID: 26536114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonclinical safety profile of telbivudine, a novel potent antiviral agent for treatment of hepatitis B.
    Bridges EG; Selden JR; Luo S
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2521-8. PubMed ID: 18474576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo efficacy and pharmacological properties of a novel glycopeptide (YV4465) against vancomycin-intermediate Staphylococcus aureus.
    Yarlagadda V; Konai MM; Paramanandham K; Nimita VC; Shome BR; Haldar J
    Int J Antimicrob Agents; 2015 Oct; 46(4):446-50. PubMed ID: 26188396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonclinical Safety Profile of Revusiran, a 1st-Generation GalNAc-siRNA Conjugate for Treatment of Hereditary Transthyretin-Mediated Amyloidosis.
    Sutherland JE; Hettinger JL; Chan A; Gilbert J; Warner GL; Davis WP
    Nucleic Acid Ther; 2020 Feb; 30(1):33-49. PubMed ID: 31821125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Intraarticular Antibiotic Administration Effective in the Treatment of Methicillin-Resistant Staphylococcus aureus?
    Kuyucu E; Çabuk H; Güler Y; Çabuk F; Kiliç E; Bülbül M
    Acta Chir Orthop Traumatol Cech; 2019; 86(4):276-280. PubMed ID: 31524589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Nonclinical Safety Profile of GalNAc-conjugated RNAi Therapeutics in Subacute Studies.
    Janas MM; Harbison CE; Perry VK; Carito B; Sutherland JE; Vaishnaw AK; Keirstead ND; Warner G
    Toxicol Pathol; 2018 Oct; 46(7):735-745. PubMed ID: 30139307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonclinical safety of ziconotide: an intrathecal analgesic of a new pharmaceutical class.
    Skov MJ; Beck JC; de Kater AW; Shopp GM
    Int J Toxicol; 2007; 26(5):411-21. PubMed ID: 17963128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.